PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
Abstract Background Alpha-fetoprotein (AFP) is a key biomarker for hepatocellular carcinoma (HCC), but 30–40% of cases are AFP-negative. Prothrombin induced by vitamin K absence II (PIVKA-II) is more sensitive for HCC detection, though its role in systemic therapy remains underexplored. This study a...
Saved in:
Main Authors: | San-Chi Chen, Hsiang-Ling Ho, Chien-An Liu, Yi‑Ping Hung, Nai-Jung Chiang, Ming‑Huang Chen, Yee Chao, Muh-Hwa Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13568-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane
by: Yinglian Pan, et al.
Published: (2025-02-01) -
Autoimmune hepatitis with abnormally high level of serum alpha-fetoprotein (Clinical case)
by: A. O. Bueverov, et al.
Published: (2010-02-01) -
Selectividad, timing y liderazgo de los multifondos-AFP en Chile
by: Eduardo Sandoval Álamos, et al.
Published: (2018-01-01) -
Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma
by: Shen Lihong, et al.
Published: (2025-02-01) -
Fetal Sacrococcygeal Teratoma: A Case Report of a Giant Tumor with an Excellent Outcome
by: Anna Kornete, et al.
Published: (2023-11-01)